Subscription to raise £900,000 to progress proprietary TYK2/JAK1 programmes through final stages of preclinical development
Sareum Holdings PLC (SAR.L) Research Update
Sareum Notes SRA737 Combination Data to be Presented at the AACR Annual Meeting
Sareum Holdings PLC (SAR.L) Research Update
Encouraging Preclinical Results Generated with Sareum’s TYK2/JAK1 Inhibitors in a Disease Model of Lupus
SimiGon Ltd (LON:SIM) SimiGon signs Blanket Purchase Agreement with the US Department of Defense
SimiGon President and CEO, Ami Vizer, said: “We are delighted to join DoD ESI under this BPA. Through signing the BPA, SimiGon joins blue chip technology companies such as IBM,